Telomerase ECT Biomarker Study From Ireland: Negative results
Out on PubMed, from colleagues in Ireland, is this study: PBMC telomerase activity in depression and the response to electroconvulsive therapy. Ryan KM, Finnegan M, Harkin A, McLoughlin DM. Eur Arch Psychiatry Clin Neurosci. 2021 Jul 15. doi: 10.1007/s00406-021-01294-4. Online ahead of print. PMID: 34268617 The abstract is copied below: Telomerase, the DNA polymerase responsible for maintaining telomere length, has previously been implicated in depression and the response to antidepressant drugs. In this study, we aimed to compare telomerase activity in peripheral blood mononuclear cells between patients with severe depression recruited as part of the KEEP-WELL Trial (Ketamine for Depression Relapse Prevention Following ECT; NCT02414932 ) and age- and sex-matched healthy volunteers both at baseline/pre-ECT and at follow-up 1 month later for controls or in patients after a course of ECT. We found no differences in telomerase activity between patients with depression (n = 20) ...